scholarly journals The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region

1992 ◽  
Vol 66 (5) ◽  
pp. 912-916 ◽  
Author(s):  
D Serraino ◽  
G Salamina ◽  
S Franceschi ◽  
D Dubois ◽  
C La Vecchia ◽  
...  
Keyword(s):  
World Health Organization ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
World Health ◽  
European Region ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The World ◽  
Health Organization

California's Glyphosate Judgement – Emotion, Bad Science and Greed Win the Day

2018 ◽  
Vol 29 (5) ◽  
pp. 204-205
Author(s):  
Alex Berezow
Keyword(s):  
World Health Organization ◽  
Hodgkin’S Lymphoma ◽  
Hot Water ◽  
Hodgkin's Lymphoma ◽  
World Health ◽  
International Agency ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The World ◽  
Health Organization

Jurors in California have awarded $289 million to a man who claimed that his cancer was due to Monsanto's herbicide glyphosate, even though that is biologically impossible. Even the judge acknowledged that there was no evidence of harm. Yet, trial lawyers manipulated a jury's emotions and the public's misunderstanding of science to score another jackpot verdict. The plaintiff, Dewayne Johnson, claims that glyphosate gave him non-Hodgkin's lymphoma, a cancer that occurs when the immune system goes awry. There are three major problems with this claim. First, as stated above, glyphosate does not cause cancer because it does not harm humans. It is an herbicide, so it is only toxic to plants. There is no known biological mechanism by which glyphosate could cause cancer, therefore its carcinogenicity is not even theoretically possible. That is why there is not a single reputable public health agency that believes glyphosate causes cancer. The US Environmental Protection Agency, the World Health Organization, and the European Food Safety Authority all reject claims of any link. The only organization of note that rejects this scientific consensus is a group within the World Health Organization called the International Agency for Research on Cancer (IARC). Contrary to all evidence, the group insists that glyphosate causes cancer – along with bacon and hot water. The truth is that IARC is a fringe outlier, staunchly ideological rather than scientific, and rife with financial conflicts of interest. Christopher Portier, a special adviser to the IARC working group that examined glyphosate, was also working for the activist organization the Environmental Defense Fund and received $160,000 from trial lawyers who stood to profit handsomely if IARC declared glyphosate a carcinogen because they could file suits in lawsuit-happy California. IARC's credibility has been so thoroughly shattered that Congress recently pulled its funding. Secondly, although the root cause of non-Hodgkin's lymphoma is unknown, that does not mean its etiology is completely open to speculation. Lymphomas originate from white blood cells, so scientists believe that autoimmune disease or chronic infections play a role. Just because the plaintiff's attorneys can fool a jury into believing that glyphosate causes non-Hodgkin's lymphoma does not mean there is any scientific evidence – and there is not. Thirdly, glyphosate has been off-patent for 18 years, and about 40% of the world's glyphosate is made in China. So, why pick on Monsanto when several different companies could have supplied the glyphosate the plaintiff used?

scholarly journals Secondary Leukemia in a non-Hodgkin's Lymphoma Patient Presenting as Myeloid Sarcoma of the Breast

2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Vincenzo Pitini ◽  
Carmela Arrigo ◽  
Maria Grazia Sauta ◽  
Giuseppe Altavilla
Keyword(s):  
Hodgkin’S Lymphoma ◽  
Myeloid Sarcoma ◽  
Hodgkin's Lymphoma ◽  
World Health ◽  
Secondary Leukemia ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Immature Myeloid Cells ◽  
Classification Of Tumors ◽  
Health Organization

As defined by the World Health Organization classification of tumors of hematopoietic and lymphoid tissue, myeloid sarcoma (MS) is a tumor mass of myeloblasts or immature myeloid cells that can arise before, concurrent with, or following acute myeloid leukaemia. We describe a case of secondary leukemia presenting itself as MS of the breast in a patient previously treated for a non-Hodgkin's Lymphoma.

scholarly journals Primary B-Cell Lymphoma of Caecum Presenting as an Ulcerative Lesion in a Young Male

2020 ◽  
Vol 11 (02) ◽  
pp. 159-162
Author(s):  
Arvind Bamanikar ◽  
Swapnil Patil ◽  
Shivam Sharma
Keyword(s):  
B Cell ◽  
Hodgkin’S Lymphoma ◽  
Cell Lymphoma ◽  
Young Male ◽  
B Cell Lymphoma ◽  
Hodgkin's Lymphoma ◽  
World Health ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Health Organization

AbstractExtra nodal site of non–Hodgkin’s lymphoma is mostly in the gastrointestinal tract. Large intestine is rarely affected compared with stomach or small bowel. The colon is affected in 0.4% of cases approximately. High index of suspicion is required to establish the diagnosis, since there may be no specific signs. Here we report a case of a 28-year-old male, who presented with diarrhea , abdominal pain and weight loss of 2-month duration and diagnosed as non-Hodgkin’s lymphoma (NHL) of the cecum as B-cell lymphoma, unclassified (BCLU) according to World Health Organization (WHO) guidelines.

scholarly journals Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

2020 ◽  
Vol 25 (32) ◽  
Author(s):  
Erik Alm ◽  
Eeva K Broberg ◽  
Thomas Connor ◽  
Emma B Hodcroft ◽  
Andrey B Komissarov ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Data Dissemination ◽  
Sequence Data ◽  
Temporal Distribution ◽  
World Health ◽  
European Region ◽  
The World ◽  
Health Organization ◽  
Over Time

We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.

scholarly journals National Recommendations for Infant and Young Child Feeding in the World Health Organization European Region

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Berthold Koletzko ◽  
Nathali Lehmann Hirsch ◽  
Jo Martin Jewell ◽  
Quenia Dos Santos ◽  
João Breda ◽  
...  
Keyword(s):  
Young Child ◽  
World Health Organization ◽  
World Health ◽  
European Region ◽  
Child Feeding ◽  
Young Child Feeding ◽  
Infant And Young Child ◽  
The World ◽  
Health Organization
Sign in / Sign up

Export Citation Format

Share Document